{"id":2817,"date":"2025-02-05T12:23:36","date_gmt":"2025-02-05T09:23:36","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2817"},"modified":"2025-09-07T12:46:40","modified_gmt":"2025-09-07T09:46:40","slug":"russian-biotech-company-generium-has-begun-clinical-trials-of-a-gene-therapy-for-duchenne-muscular-dystrophy","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/es\/russian-biotech-company-generium-has-begun-clinical-trials-of-a-gene-therapy-for-duchenne-muscular-dystrophy\/","title":{"rendered":"La empresa rusa de biotecnolog\u00eda Generium ha iniciado ensayos cl\u00ednicos de una terapia gen\u00e9tica para la distrofia muscular de Duchenne"},"content":{"rendered":"<p class=\"wp-block-paragraph\">En la Universidad Sirius y la empresa biotecnol\u00f3gica rusa Generium han comenzado los estudios cl\u00ednicos para una terapia contra la distrofia muscular de Duchenne. En una reuni\u00f3n celebrada en la Universidad Estatal de Novosibirsk, Dmitry Kudlai, miembro de la Academia Rusa de Ciencias, ofreci\u00f3 sus perspectivas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A\u00fan no hay informaci\u00f3n sobre ensayos cl\u00ednicos de la terapia g\u00e9nica para la distrofia muscular de Duchenne en el Registro Estatal de Medicamentos de Rusia. Como guerreros de la distrofia muscular de Duchenne, estaremos atentos a estas declaraciones.<\/p>","protected":false},"excerpt":{"rendered":"<p>Clinical studies for a therapy for Duchenne muscular dystrophy have begun at Sirius University and the Russian biotech business Generium. At a gathering at Novosibirsk State University, Dmitry Kudlai, a Member of the Russian Academy of Sciences, offered his perspectives. There is no clinical trial information for the Duchenne muscular dystrophy gene therapy in the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2818,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[137,242,61,241,414,135],"class_list":["post-2817","post","type-post","status-publish","format-standard","has-post-thumbnail","category-research","tag-clinical-trial","tag-clinical-trials","tag-gene-therapy","tag-generium","tag-gnr-097","tag-russia"],"subtitle":"Seg\u00fan un art\u00edculo publicado por el portal de noticias GXPNEWS, la empresa biotecnol\u00f3gica rusa Generium comenzar\u00e1 a trabajar en una terapia gen\u00e9tica para el tratamiento de la distrofia muscular de Duchenne.","_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts\/2817","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/comments?post=2817"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts\/2817\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/media\/2818"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/media?parent=2817"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/categories?post=2817"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/tags?post=2817"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}